Ionis Pharmaceuticals, Inc. Increase (Decrease) in Inventories
Ionis Pharmaceuticals, Inc. (IONS) reported Increase (Decrease) in Inventories of $24.63 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2026-07-29
- Ionis Pharmaceuticals, Inc. increase (decrease) in inventories for the quarter ending 2026-06-30 was $24.96M, a 85.26% increase year-over-year.
- Ionis Pharmaceuticals, Inc. increase (decrease) in inventories for the quarter ending 2026-03-31 was -$338.00K.
- Ionis Pharmaceuticals, Inc. increase (decrease) in inventories for the quarter ending 2025-12-31 was -$926.00K, a 118.36% decline year-over-year.
- Ionis Pharmaceuticals, Inc. increase (decrease) in inventories for the quarter ending 2025-09-30 was $2.13M.
- Ionis Pharmaceuticals, Inc. increase (decrease) in inventories for fiscal 2025 was $13.67M, a 169.65% increase from fiscal 2024.
- Ionis Pharmaceuticals, Inc. increase (decrease) in inventories for fiscal 2024 was $5.07M, a 105.39% increase from fiscal 2023.
- Ionis Pharmaceuticals, Inc. increase (decrease) in inventories for fiscal 2023 was $2.47M.
- Ionis Pharmaceuticals, Inc. increase (decrease) in inventories for fiscal 2022 was -$5.33M, a 287.47% decline from fiscal 2021.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 3 month as first filed | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 12 month | Increase (Decrease) in Inventories 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | $24.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $24.63M 10-Q · filed 2026-07-29 | $23.70M derived: sum of 3 quarters · filed 2026-07-29 | $25.84M derived: sum of 4 quarters · filed 2026-07-29 | ||
| 2026-03-31 | -$338.00K 10-Q · filed 2026-04-29 | -$1.26M derived: sum of 2 quarters · filed 2026-04-29 | $871.00K derived: sum of 3 quarters · filed 2026-04-29 | $14.35M derived: sum of 4 quarters · filed 2026-07-29 | ||
| 2025-12-31 | -$926.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.21M derived: sum of 2 quarters · filed 2026-02-26 | $14.68M derived: sum of 3 quarters · filed 2026-07-29 | $13.67M 10-K · filed 2026-02-26 | ||
| 2025-09-30 | $2.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $15.61M derived: sum of 2 quarters · filed 2026-07-29 | $14.60M 10-Q · filed 2025-10-29 | $19.64M derived: sum of 4 quarters · filed 2026-07-29 | ||
| 2025-06-30 | $13.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $12.46M 10-Q · filed 2026-07-29 | $17.51M derived: sum of 3 quarters · filed 2026-07-29 | $17.24M derived: sum of 4 quarters · filed 2026-07-29 | ||
| 2025-03-31 | -$1.01M 10-Q · filed 2026-04-29 | $4.03M derived: sum of 2 quarters · filed 2026-04-29 | $3.76M derived: sum of 3 quarters · filed 2026-04-29 | $4.56M derived: sum of 4 quarters · filed 2026-04-29 | ||
| 2024-12-31 | $5.04M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $4.77M derived: sum of 2 quarters · filed 2026-02-26 | $5.57M derived: sum of 3 quarters · filed 2026-02-26 | $5.07M 10-K · filed 2026-02-26 | ||
| 2024-09-30 | -$271.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $526.00K derived: sum of 2 quarters · filed 2025-10-29 | $27.00K 10-Q · filed 2025-10-29 | -$1.10M derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2024-06-30 | $797.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-30 | $298.00K 10-Q · filed 2025-07-30 | -$834.00K derived: sum of 3 quarters · filed 2026-02-26 | -$738.00K derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2024-03-31 | -$499.00K 10-Q · filed 2025-04-30 | $1.83M 10-Q · filed 2024-05-07 | -$1.63M derived: sum of 2 quarters · filed 2026-02-26 | -$1.53M derived: sum of 3 quarters · filed 2026-02-26 | $1.80M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2023-12-31 | -$1.13M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$1.04M derived: sum of 2 quarters · filed 2026-02-26 | $2.30M derived: sum of 3 quarters · filed 2026-02-26 | $2.47M 10-K · filed 2026-02-26 | $6.39M 10-K · filed 2024-02-21 | |
| 2023-09-30 | $96.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $3.43M derived: sum of 2 quarters · filed 2024-11-06 | $3.60M 10-Q · filed 2024-11-06 | $2.44M derived: sum of 4 quarters · filed 2025-02-19 | ||
| 2023-06-30 | $3.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $3.50M 10-Q · filed 2024-08-01 | $2.34M derived: sum of 3 quarters · filed 2025-02-19 | $3.17M derived: sum of 4 quarters · filed 2025-02-19 | ||
| 2023-03-31 | $167.00K 10-Q · filed 2024-05-07 | -$998.00K derived: sum of 2 quarters · filed 2025-02-19 | -$164.00K derived: sum of 3 quarters · filed 2025-02-19 | -$4.38M derived: sum of 4 quarters · filed 2025-02-19 | ||
| 2022-12-31 | -$1.17M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-19 | -$331.00K derived: sum of 2 quarters · filed 2025-02-19 | -$4.55M derived: sum of 3 quarters · filed 2025-02-19 | -$5.33M 10-K · filed 2025-02-19 | -$2.77M 10-K · filed 2023-02-22 | |
| 2022-09-30 | $834.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | -$3.39M derived: sum of 2 quarters · filed 2023-11-02 | -$4.16M 10-Q · filed 2023-11-02 | -$2.29M derived: sum of 4 quarters · filed 2024-02-21 | ||
| 2022-06-30 | -$4.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$5.00M 10-Q · filed 2023-08-09 | -$3.12M derived: sum of 3 quarters · filed 2024-02-21 | -$4.29M derived: sum of 4 quarters · filed 2024-02-21 | ||
| 2022-03-31 | -$774.00K 10-Q · filed 2023-05-03 | $1.10M derived: sum of 2 quarters · filed 2024-02-21 | -$67.00K derived: sum of 3 quarters · filed 2024-02-21 | $1.83M derived: sum of 4 quarters · filed 2024-02-21 | ||
| 2021-12-31 | $1.88M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $707.00K derived: sum of 2 quarters · filed 2024-02-21 | $2.61M derived: sum of 3 quarters · filed 2024-02-21 | $2.84M 10-K · filed 2024-02-21 | ||
| 2021-09-30 | -$1.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $731.00K derived: sum of 2 quarters · filed 2022-11-09 | $965.00K 10-Q · filed 2022-11-09 | $758.00K derived: sum of 4 quarters · filed 2023-02-22 | ||
| 2021-06-30 | $1.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $2.13M 10-Q · filed 2022-08-09 | $1.93M derived: sum of 3 quarters · filed 2023-02-22 | $377.00K derived: sum of 4 quarters · filed 2023-02-22 | ||
| 2021-03-31 | $234.00K 10-Q · filed 2022-05-04 | $27.00K derived: sum of 2 quarters · filed 2023-02-22 | -$1.52M derived: sum of 3 quarters · filed 2023-02-22 | -$686.00K derived: sum of 4 quarters · filed 2023-02-22 | ||
| 2020-12-31 | -$207.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | -$1.76M derived: sum of 2 quarters · filed 2023-02-22 | -$920.00K derived: sum of 3 quarters · filed 2023-02-22 | $1.26M 10-K · filed 2023-02-22 | ||
| 2020-09-30 | -$1.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | -$713.00K derived: sum of 2 quarters · filed 2021-11-03 | $1.47M 10-Q · filed 2021-11-03 | $273.00K derived: sum of 4 quarters · filed 2022-02-25 | ||
| 2020-06-30 | $837.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $3.02M 10-Q · filed 2021-08-04 | $1.82M derived: sum of 3 quarters · filed 2022-02-25 | $2.69M derived: sum of 4 quarters · filed 2022-02-25 | ||
| 2020-03-31 | $2.18M 10-Q · filed 2021-05-05 | $986.00K derived: sum of 2 quarters · filed 2022-02-25 | $1.86M derived: sum of 3 quarters · filed 2022-02-25 | $5.12M derived: sum of 4 quarters · filed 2022-02-25 | ||
| 2019-12-31 | -$1.20M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | -$325.00K derived: sum of 2 quarters · filed 2022-02-25 | $2.94M derived: sum of 3 quarters · filed 2022-02-25 | $5.41M 10-K · filed 2022-02-25 | ||
| 2019-09-30 | $870.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | $4.13M derived: sum of 2 quarters · filed 2020-11-04 | $6.61M 10-Q · filed 2020-11-04 | $6.81M derived: sum of 4 quarters · filed 2021-02-24 | ||
| 2019-06-30 | $3.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $5.74M 10-Q · filed 2020-08-05 | $5.94M derived: sum of 3 quarters · filed 2021-02-24 | $5.25M derived: sum of 4 quarters · filed 2021-02-24 | ||
| 2019-03-31 | $2.48M 10-Q · filed 2020-05-06 | $2.68M derived: sum of 2 quarters · filed 2021-02-24 | $1.99M derived: sum of 3 quarters · filed 2021-02-24 | $2.00M derived: sum of 4 quarters · filed 2021-02-24 | ||
| 2018-12-31 | $204.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | -$485.00K derived: sum of 2 quarters · filed 2021-02-24 | -$478.00K derived: sum of 3 quarters · filed 2021-02-24 | -$1.40M 10-K · filed 2021-02-24 | ||
| 2018-09-30 | -$689.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | -$682.00K derived: sum of 2 quarters · filed 2019-11-06 | -$1.60M 10-Q · filed 2019-11-06 | -$73.00K derived: sum of 4 quarters · filed 2020-03-02 | ||
| 2018-06-30 | $7.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$915.00K 10-Q · filed 2019-08-08 | $616.00K derived: sum of 3 quarters · filed 2020-03-02 | $2.56M derived: sum of 4 quarters · filed 2020-03-02 | ||
| 2018-03-31 | -$922.00K 10-Q · filed 2019-05-09 | $609.00K derived: sum of 2 quarters · filed 2020-03-02 | $2.56M derived: sum of 3 quarters · filed 2020-03-02 | $2.26M derived: sum of 4 quarters · filed 2020-03-02 | ||
| 2017-12-31 | $1.53M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $3.48M derived: sum of 2 quarters · filed 2020-03-02 | $3.18M derived: sum of 3 quarters · filed 2020-03-02 | $2.49M 10-K · filed 2020-03-02 | ||
| 2017-09-30 | $1.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $1.65M derived: sum of 2 quarters · filed 2018-11-06 | $962.00K 10-Q · filed 2018-11-06 | -$868.00K derived: sum of 4 quarters · filed 2019-03-01 | ||
| 2017-06-30 | -$297.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | -$985.00K 10-Q · filed 2018-08-07 | -$2.81M derived: sum of 3 quarters · filed 2019-03-01 | -$1.16M derived: sum of 4 quarters · filed 2019-03-01 | ||
| 2017-03-31 | -$688.00K 10-Q · filed 2018-05-07 | -$2.52M derived: sum of 2 quarters · filed 2019-03-01 | -$867.00K derived: sum of 3 quarters · filed 2019-03-01 | $281.00K derived: sum of 4 quarters · filed 2019-03-01 | ||
| 2016-12-31 | -$1.83M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | -$179.00K derived: sum of 2 quarters · filed 2019-03-01 | $969.00K derived: sum of 3 quarters · filed 2019-03-01 | $590.00K 10-K · filed 2019-03-01 | ||
| 2016-09-30 | $1.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $2.80M derived: sum of 2 quarters · filed 2017-11-07 | $2.42M 10-Q · filed 2017-11-07 | $2.74M derived: sum of 4 quarters · filed 2018-02-28 | ||
| 2016-06-30 | $1.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $769.00K 10-Q · filed 2017-08-09 | $1.08M derived: sum of 3 quarters · filed 2018-02-28 | $886.00K derived: sum of 4 quarters · filed 2018-02-28 | ||
| 2016-03-31 | -$379.00K 10-Q · filed 2017-05-09 | -$63.00K derived: sum of 2 quarters · filed 2018-02-28 | -$262.00K derived: sum of 3 quarters · filed 2018-02-28 | -$319.00K derived: sum of 4 quarters · filed 2018-02-28 | ||
| 2015-12-31 | $316.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | $117.00K derived: sum of 2 quarters · filed 2018-02-28 | $60.00K derived: sum of 3 quarters · filed 2018-02-28 | $609.00K 10-K · filed 2018-02-28 | ||
| 2015-09-30 | -$199.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | -$256.00K derived: sum of 2 quarters · filed 2016-11-09 | $293.00K 10-Q · filed 2016-11-09 | -$502.00K derived: sum of 4 quarters · filed 2017-03-01 | ||
| 2015-06-30 | -$57.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $492.00K 10-Q · filed 2016-08-09 | -$303.00K derived: sum of 3 quarters · filed 2017-03-01 | -$994.00K derived: sum of 4 quarters · filed 2017-03-01 | ||
| 2015-03-31 | $549.00K 10-Q · filed 2016-05-05 | -$246.00K derived: sum of 2 quarters · filed 2017-03-01 | -$937.00K derived: sum of 3 quarters · filed 2017-03-01 | -$698.00K derived: sum of 4 quarters · filed 2017-03-01 | ||
| 2014-12-31 | -$795.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | -$1.49M derived: sum of 2 quarters · filed 2017-03-01 | -$1.25M derived: sum of 3 quarters · filed 2017-03-01 | -$1.74M 10-K · filed 2017-03-01 | ||
| 2014-09-30 | -$691.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | -$452.00K derived: sum of 2 quarters · filed 2015-11-09 | -$948.00K 10-Q · filed 2015-11-09 | -$300.00K derived: sum of 4 quarters · filed 2016-02-26 | ||
| 2014-06-30 | $239.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | -$257.00K 10-Q · filed 2015-08-05 | $391.00K derived: sum of 3 quarters · filed 2016-02-26 | -$533.00K derived: sum of 4 quarters · filed 2016-02-26 | ||
| 2014-03-31 | -$496.00K 10-Q · filed 2015-05-05 | $152.00K derived: sum of 2 quarters · filed 2016-02-26 | -$772.00K derived: sum of 3 quarters · filed 2016-02-26 | $1.73M derived: sum of 4 quarters · filed 2016-02-26 | ||
| 2013-12-31 | $648.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | -$276.00K derived: sum of 2 quarters · filed 2016-02-26 | $2.22M derived: sum of 3 quarters · filed 2016-02-26 | $1.91M 10-K · filed 2016-02-26 | ||
| 2013-09-30 | -$924.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | $1.58M derived: sum of 2 quarters · filed 2014-11-07 | $1.26M 10-Q · filed 2014-11-07 | |||
| 2013-06-30 | $2.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-04 | $2.19M 10-Q · filed 2014-08-04 | ||||
| 2013-03-31 | -$312.00K 10-Q · filed 2014-05-06 | |||||
| 2012-12-31 | $1.98M 10-K · filed 2015-03-02 | |||||
| 2011-12-31 | $1.66M 10-K · filed 2014-03-03 | |||||
| 2010-12-31 | -$284.00K 10-K · filed 2013-02-28 | |||||
| 2009-12-31 | $17.00K 10-K · filed 2012-02-29 | |||||
| 2008-12-31 | $1.32M 10-K · filed 2011-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |